Clinical Applications: Real-World Solutions That Transform Patient Care

Discover real-world clinical applications that transform patient care. In modern practice, clinical applications turn complex microbiome data into actionable steps—risk assessment, personalized interventions, and ongoing monitoring that shape better health outcomes. InnerBuddies offers a white-label Gut Health Operating System designed to power these clinical applications across brands, clinics, and consumer platforms. At its core is the Gut Microbiome Health Index, a 0–100 score that reflects overall gut health, developed under an exclusive IP agreement with EAFIT University in Colombia. This provides a standardized, interpretable metric clinicians can rely on as part of decision-making. Learn more about how this capability works with the InnerBuddies microbiome test and the supporting tools that anchor practical clinical applications today. Beyond the index, clinicians gain clarity from granular microbiome data designed for direct clinical impact. InnerBuddies exposes the top 40 bacteria with abundances and shows how a patient compares to a healthy cohort, helping identify dysbiosis patterns that may inform treatment. Bacterial functions are categorized and labeled as positive or negative, with per-function comparisons to healthy baselines to guide targeted actions. The platform also offers Target Group analysis—deep dives into how the microbiome behaves in contexts such as Healthy Aging, Endurance Sport, Power Sport, and Skin & Hair Health—so clinicians can align recommendations with patient goals. Taken together, these clinical applications support improved risk stratification and therapy planning in real-world care. Personalized nutrition and supplement guidance amplify clinical outcomes. By integrating three-day food diaries with stool data, InnerBuddies builds a robust database that links individual foods to microbiome shifts. This foundation enables personalized nutrition advice tailored to each patient’s unique gut signature, improving adherence and effectiveness. At the same time, personalized probiotics and prebiotics recommendations are generated to match objectives and microbiome composition. These clinical applications are accessible to consumers as well, reflecting the platform’s seamless B2B and direct-to-consumer capabilities. Explore consumer-accessible options on the microbiome test page, or learn about ongoing benefits via the gut health membership. InnerBuddies also delivers gut test solutions directly targeted to consumers, with all B2B options available for brands and healthcare providers to deploy their own programs. To learn about partnering and how to embed these clinical applications into your offering, visit the B2B partner program page. Whether you’re expanding clinical services in a clinic, launching a branded gut health product, or empowering patients with at-home testing, InnerBuddies equips you with real-world clinical applications that drive proven outcomes and better health today.